DempoChem Logo
  1. HomeHome
  2. /ProductsProducts
  3. /Bioactive CompoundsBioactive Compounds
  4. /Metabolic EnzymesMetabolic Enzymes
  5. /GlucokinaseGlucokinase
  6. /Bms-820132Bms-820132
Chemical structure of CAS 1001419-18-6

Bms-820132

In Stock•Starting at $839 for 5 mg•Purity ≥ 98%
CAS No.1001419-18-6
MDL No.N/A
MFC26H33N6O7P
MW572.50
InChI KeyOYUDYQMFVRHPIY-UHFFFAOYSA-N
CUSTOM SYNTHESIS

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
5 mg98%$839In Stock
10 mg98%$1477In Stock
25 mg98%$2598In Stock
100 mg98%$7260In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.1001419-18-6
Product NameBms-820132
Heavy Atom Count40Rotatable Bond Count13
Atom Stereo Count0Bond Stereo Count0
HBA11HBD1
TPSA147.000 ŲCharge0
Exact Mass572.21483Complexity1364.12
pKa5.875XLogP4.574

Related Articles

Studies related to this compound and its mechanism of action

Discovery of a Partial Glucokinase Activator Clinical Candidate: Diethyl ((3-(3-((5-(Azetidine-1-carbonyl)pyrazin-2-yl)oxy)-5-isopropoxybenzamido)-1-pyrazol-1-yl)methyl)phosphonate (BMS-820132).

Journal of medicinal chemistry • Vol. 65, Issue 5 • 2022
PMID: 35179904DOI: 10.1021/acs.jmedchem.1c02110

Documentation

Similar Products

  • Azd-1656

    CAS No.919783-22-5

Your Partner for
Complex Chemistry
logo
  • About Us
  • Perspectives
  • Products
  • Contact
  • Preclinical Development
  • Technologies
  • Custom Synthesis
Ready to start your project?

Provide your target molecule or project specifications to align on a tailored development and scale-up pathway with our scientific team.

START A PROJECT
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
logo

All products are supplied strictly for research and development use only and are not intended for human or veterinary administration, diagnostic use, or therapeutic use. Preclinical and related services are provided solely for research and development purposes and do not constitute clinical diagnosis, treatment, or veterinary care.

©2026 DempoChem. All Rights Reserved.
DHLFedExUPSPostNL
CLIENT PORTAL|TERMS AND CONDITIONS|PRIVACY POLICY|
  • Products
    • CDMO Compounds
    • API & Candidates
  • Services
    CDMO & Manufacturing
    • Custom Synthesis
    • Process Development
    • Lab To Pilot
    • Commercialization
    • Generic APIs
    CRO
    • Preclinical
    • Pharmacology & Efficacy
    • DMPK & Bioanalysis
    • Toxicology & Safety
    • Disease Models
    Technologies
    • High-Potent
    • Chiral Synthesis
    • Cloud Synthesis
    • Fermentation
    • Flow Chemistry
    • Biocatalysis
    Support
    • Regulatory Support
    • Supply Chain Solutions
  • About
  • Perspectives
  • Contact